After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Get the (QMED) Report Here
Trade with Jim Cramer 14 Days FREE
Also, Nicholas Yulico will take another look at American Capital Strategies.
RadiSys surges on a quarterly earnigns beat.
Sanofi slides on a regulatory hit.
QMed rises more than 13%.
Taro Pharmaceutical's third-quarter results come in well below expectations.
Discovery Labs rises on tentative FDA approval of Surfaxin.
Corgentech takes it on the chin.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.